Financials

  • Market Capitalization 3.47 B
  • Employee 755
  • Founded 2006
  • CEO N/A
  • Website www.veracyte.com
  • Headquarter Delaware, United States
  • FIGI BBG001J2M542
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
51.34
Rapporto prezzo/fatturato
6.56

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
1511
TNGX
Tango Therapeutics, Inc. - Common Stock
22.22 USD-8.07%+2.68%-9.49%+154.23%3.75 B USD
1518
TLX
Telix Pharmaceuticals Limited - American Depositary Shares
10.92 USD-3.28%-0.82%-13.47%+73.06%3.70 B USD
1581
XENE
Xenon Pharmaceuticals Inc. - Common Shares
34.42 USD-3.88%-4.89%-40.79%-15.62%3.33 B USD
1588
LEGN
Legend Biotech Corporation - American Depositary Shares
17.88 USD+0.45%-4.79%-3.87%-44.09%3.31 B USD

Notizie